Researchers have linked upper gastrointestinal tract damage to a higher risk for developing Parkinson’s disease. The report, published Sept. 5 in JAMA Network Open, showed that mucosal damage seen on ...

Upper GI mucosal damage was tied to a 76% higher risk of subsequent Parkinson's disease. The retrospective study followed GI patients for nearly 15 years. The findings support literature suggesting ...

In a small 10-week study, patients who took 70 mg of alendronate once weekly did not show increased endoscopic evidence of upper gastrointestinal pathology compared with placebo recipients (Journal ...

Using data from the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS), Dr. Qiao-Li Wang and colleagues recently set out to further characterize the association between ...

The BREAKWATER trial demonstrated the efficacy of a BRAF-targeted regimen using FOLFIRI, offering a neuropathy-free option for metastatic colorectal cancer patients. HERIZON-GEA-01 trial results ...